Autel to Showcase Breakthrough EV Charging Innovations at ICNC23
29.8.2023 12:21:00 EEST | Business Wire | Press release
Autel Energy, a leading provider of innovative EV charging solutions, is pleased to announce its participation in the highly-anticipated Intercharge Network Conference 2023 (ICNC23) to be held on August 29-31, 2023, in Berlin. Ting Cai, CEO of Autel Europe, is set to captivate the audience with an insightful speech on the future of EV charging. Autel's hallmark innovation, the MaxiCharger DC Compact, will take center stage as it makes a live demonstration at the Plug&Charge Showcase Zone to showcase its seamless charging process.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230828771064/en/
Complete MaxiCharger Lineup Unveiled at ICNC23 and IAA MOBILITY 2023 (Graphic: Business Wire)
ICNC23 is renowned for bringing together top industry professionals, experts, and stakeholders in the electric vehicle charging infrastructure domain. Ting Cai’s speech and Autel’s charging capabilities of its products will provide attendees with an exclusive opportunity to experience first-hand the cutting-edge technology that Autel Energy has brought to the market.
Autel MaxiCharger series offer a revolutionary charging solution that has transformed the charging experience for electric vehicle owners. With its high-speed charging capabilities, intuitive user interface, and compatibility with various electric vehicle models, Autel has earned its reputation as an indispensable tool for EV owners. Notably, Autel Energy has been officially checked and validated by Hubject, making its way into the Plug&Charge ecosystem. At ICNC23, Autel will bring its MaxiCharger DC Compact to demonstrate the charging process at the Plug&Charge Showcase Zone, which will impeccably showcase its exceptional features, emphasizing its role in providing a seamless and efficient charging process for electric vehicles.
Following the ICNC23, Autel Energy is excited to continue its engagement with the electric vehicle community at IAA MOBILITY 2023 (International Motor Show Germany) to take place on September 5-10, 2023, in Munich. During this period, Autel will embark on a roadshow, with its event vehicles journeying from ICNC in Berlin all the way to IAA MOBILITY in Munich and ultimately welcoming visitors at booth C2 A31.
"We are delighted to be part of ICNC23 and IAA MOBILITY 2023, where we can showcase the capabilities of Autel’s EV chargers and its seamless integration with various EV models," said Ting Cai, CEO of Autel Europe. "As the EV market continues to grow, Autel Energy remains committed to delivering cutting-edge charging solutions that enhance the driving experience for EV owners worldwide."
Visitors attending ICNC23 and IAA MOBILITY will have the exclusive opportunity to explore the charging process of the demonstration EV by Autel Energy's comprehensive array of EV charging products. Autel Energy's team of experts will be available at the event to engage with visitors, share insights, and discuss the transformative potential of their cutting-edge charging solutions.
For more information about Autel Energy and its EV charging solutions, please visit: https://autelenergy.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230828771064/en/
Contact information
Jiaqi Liu
Email:jiaqi.liu@autel.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mosaic Therapeutics to Present Poster Highlighting Preclinical Data for Lead Program MOS101 at the American Association for Cancer Research (AACR) Annual Meeting 202624.3.2026 10:30:00 EET | Press release
Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company building the category leader in Synergistic Precision Oncology, today announced it will hold a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego, CA. Poster Presentation Details: Title: "Combination of the MDM2 antagonist ASTX295 and olaparib as a novel treatment option for BRCA2 mutant, TP53 wild-type solid tumors” Abstract Number: 3053 Date and Time: Monday, April 20, 2026, 2:00PM – 5:00PM PST Session Category: Novel Targets and Pathways Session: PO.ET09.09 Location: Poster Section 15 For more information and to view the Company’s abstract, visit the AACR Annual Meeting website. About ASTX295 ASTX295 is a potent, highly selective, potentially best-in-class MDM2 antagonist that has completed a phase I study (NCT03975387) in over 100 patients with advanced solid tumors. Rationally designed to exhibit a
Vonage and ServiceNow Expand their Partnership24.3.2026 10:20:00 EET | Press release
Vonage, part of Ericsson (NASDAQ: ERIC), today announced the launch of its native integration with ServiceNow Voice, built on the ServiceNow AI Platform, embedding enterprise-grade voice and real-time AI capabilities directly into ServiceNow Customer Service Management (CSM) and IT Service Management (ITSM) workflows for Vonage Contact Center (VCC) customers. Vonage provides a unified service environment for enterprise customer service and IT support teams, enabling agents to deliver exceptional customer experiences while driving improvements to service performance. The integration of VCC with ServiceNow embeds real-time voice and AI capabilities into enterprise workflows, giving them the tools their agents need to streamline case progression, automate workflows, and reduce manual effort. Through the Vonage integration, calls can automatically trigger incident categorisation, initiate ServiceNow Flow Designer subflows, and update issue resolution data in real time, helping to reduce ma
Omnes Partners With Apex Group to Tokenise Institutional Bitcoin Mining Structured Note on Base24.3.2026 10:00:00 EET | Press release
Omnes today announced a strategic partnership with Apex Group, a leading global financial services provider with over $3.5 trillion in assets serviced, to tokenise its flagship Omnes Mining Note "OMN". The OMN is an institutional grade structured note backed by Bitcoin hashrate, to be issued and managed on the Base Chain, the Ethereum L2 incubating at Coinbase, leveraging Apex Digital 3.0 for comprehensive tokenisation, administration, and transfer agency services as a fully integrated end to end solution. The OMN provides professional non-US investors with direct economic exposure to new Bitcoin production measured in hashrate, which is the computational power used to validate transactions and produce Bitcoin, without the operational complexities of managing mining infrastructure, hardware, energy, or regulatory hurdles. Issued as a secured debt note in Luxembourg, the tokenised OMN combines traditional financial structuring with blockchain enabled features, including on chain transfe
Avanzanite Expands French Operations and Appoints Constance Sabbagh as General Manager24.3.2026 08:00:00 EET | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest economy, and the appointment of Constance Sabbagh as General Manager, France. Following a €32 million Series A investment by MVM Partners announced in November 2025, Avanzanite is scaling its European infrastructure into a single, integrated platform across 32 countries – designed to bring rare disease medicines to patients in every European market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323639110/en/ Constance Sabbagh, General Manager, France “France is essential to Avanzanite’s European vision,” said Adam Plich, Co-founder and CEO of Avanzanite. “With its leadership in rare disease policy through its National Rare Disease Plans, care networks and scientific innovation, France is one of the most significant healthcare
AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs24.3.2026 08:00:00 EET | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, will present the latest updates on its innovations across its broad portfolio at the 2026 American Academy of Dermatology (AAD) Annual Meeting, taking place from March 27-31 in Denver, Colorado. Twenty-two abstracts will be presented, including late-breaking data and three oral presentations spanning Therapeutic Dermatology, Injectable Aesthetics, and Dermatological Skincare. “Galderma is on a path towards becoming the undisputed dermatology powerhouse and, as such, aims to set the bar for scientific excellence in the field. The range of data we are presenting at AAD shows the strength of our commitment to this across every part of our portfolio. Patients deserve sophisticated, effective solutions that meet their diverse and evolving needs, and our science is built to deliver exactly that.” BALDO SCASSELLATI SFORZOLINI, M.D., PH.D. GLOBAL HEAD OF R&D AND CORPORATE DEVELOPMENT GALDERMA Therapeutic Dermatology: Latest updat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom